COVID-19 revisiting inflammatory pathways of arthritis

G Schett, B Manger, D Simon, R Caporali - Nature Reviews …, 2020 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease, caused by severe
acute respiratory syndrome coronavirus 2, which predominantly affects the lungs and, under …

COVID-19 and rheumatoid arthritis crosstalk: emerging association, therapeutic options and challenges

S Dewanjee, R Kandimalla, RS Kalra, C Valupadas… - Cells, 2021 - mdpi.com
Hyperactivation of immune responses resulting in excessive release of pro-inflammatory
mediators in alveoli/lung structures is the principal pathological feature of coronavirus …

Post-COVID-19 arthritis: a case report and literature review

M Gasparotto, V Framba, C Piovella, A Doria… - Clinical …, 2021 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is the novel pathogen
responsible for the coronavirus disease 19 (COVID-19) outbreak. Researchers and …

The longitudinal immune response to coronavirus disease 2019: chasing the cytokine storm

AS Chau, AG Weber, NI Maria, S Narain… - Arthritis & …, 2021 - Wiley Online Library
The clinical progression of the severe acute respiratory syndrome coronavirus 2 infection,
coronavirus 2019 (COVID‐19), to critical illness is associated with an exaggerated immune …

Reactive arthritis after COVID-19: a case-based review

BF Kocyigit, A Akyol - Rheumatology international, 2021 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the coronavirus disease 19 (COVID-19) pandemic, which is deeply affecting the whole …

Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets

DP Misra, V Agarwal, AY Gasparyan, O Zimba - Clinical rheumatology, 2020 - Springer
The ongoing pandemic coronavirus disease 19 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is a matter of global concern …

[引用][C] COVID-19: the new challenge for rheumatologists.

F Ferro, E Elefante, C Baldini, E Bartoloni… - Clinical and …, 2020 - europepmc.org
This is a comment on" COVID-19, cytokines and immunosuppression: what can we learn
from severe acute respiratory syndrome?" Clin Exp Rheumatol. 2020 Mar-Apr; 38 (2): 337 …

The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance

ZS Wallace, S Bhana, JS Hausmann… - …, 2020 - academic.oup.com
The COVID-19 pandemic has already caused over 400 000 infections and led to over 17
000 deaths worldwide, dramatically disrupted daily life, and is placing extreme demands on …

COVID-19 infection and rheumatoid arthritis: Faraway, so close!

EG Favalli, F Ingegnoli, O De Lucia, G Cincinelli… - Autoimmunity …, 2020 - Elsevier
The outbreak of the new coronavirus infections COVID-19 in December 2019 in China has
quickly become a global health emergency. Given the lack of specific anti-viral therapies, the …

Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs

T Georgiev - Rheumatology international, 2020 - Springer
Current pandemic of coronavirus disease 2019 (COVID-19) is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite drastic containment measures …